A recombinant spike protein subunit vaccine confers protective immunity against SARS-CoV-2 infection and transmission in hamsters

Author:

Wu Yangtao1ORCID,Huang Xiaofen1,Yuan Lunzhi1ORCID,Wang Shaojuan1,Zhang Yali1ORCID,Xiong Hualong1,Chen Rirong23ORCID,Ma Jian1ORCID,Qi Ruoyao1ORCID,Nie Meifeng1,Xu Jingjing1ORCID,Zhang Zhigang1ORCID,Chen Liqiang23ORCID,Wei Min1ORCID,Zhou Ming1,Cai Minping23ORCID,Shi Yang1ORCID,Zhang Liang1,Yu Huan23,Hong Junping1,Wang Zikang1,Hong Yunda1ORCID,Yue Mingxi1,Li Zonglin1,Chen Dabing1ORCID,Zheng Qingbing1ORCID,Li Shaowei1ORCID,Chen Yixin1ORCID,Cheng Tong1ORCID,Zhang Jun1ORCID,Zhang Tianying1ORCID,Zhu Huachen23ORCID,Zhao Qinjian1ORCID,Yuan Quan1ORCID,Guan Yi23ORCID,Xia Ningshao14ORCID

Affiliation:

1. State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Life Sciences & School of Public Health, Xiamen University, Xiamen 361102, P. R. China.

2. State Key Laboratory of Emerging Infectious Diseases, University of Hong Kong, Hong Kong 999077, P. R. China.

3. Joint Institute of Virology (Shantou University and University of Hong Kong), Guangdong-Hongkong Joint Laboratory of Emerging Infectious Diseases, Shantou University, Shantou 515063, P. R. China.

4. Research Unit of Frontier Technology of Structural Vaccinology, Chinese Academy of Medical Sciences, Xiamen 361102, Fujian, China.

Abstract

A SARS-CoV-2 spike protein subunit vaccine induced humoral and cellular immune responses that protected hamsters against infection and prevented transmission.

Funder

National Natural Science Foundation of China

National Key Plan for Scientific Research and Development of China

Funding for Guangdong-Hongkong-Macau Joint Laboratory

Fujian Natural Science Foundation for Distinguished Young Scholars

The Bill &Melinda Gates Foundation

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3